Overview

A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.
Phase:
Phase 4
Details
Lead Sponsor:
Innovative Medical
Criteria
Inclusion Criteria:

- · Dry eye disease diagnosis

- Patients must currently be using Systane tears at least once a day and for at
least 1 month.

- Normal lid position and closure

- Male or female of legal age of consent

- Informed consent has been obtained

- Likely to complete all required follow-up visits

Exclusion Criteria:

- · Concurrent enrollment in an investigational drug or device study, or participation
in such a study within 30 days of entry into this study.

- Subject has a condition, or is in a situation which, in the investigator's
opinion, may put the subject at a significant risk, may confound the study
results, or may interfere significantly with the subject's participation in the
study.